BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 31287208)

  • 1. Barriers to pharmacist prescribing: a scoping review comparing the UK, New Zealand, Canadian and Australian experiences.
    Zhou M; Desborough J; Parkinson A; Douglas K; McDonald D; Boom K
    Int J Pharm Pract; 2019 Dec; 27(6):479-489. PubMed ID: 31287208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacist prescribing: A scoping review about the views and experiences of patients and the public.
    Famiyeh IM; McCarthy L
    Res Social Adm Pharm; 2017; 13(1):1-16. PubMed ID: 26898951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stakeholders' views and experiences of pharmacist prescribing: a systematic review.
    Jebara T; Cunningham S; MacLure K; Awaisu A; Pallivalapila A; Stewart D
    Br J Clin Pharmacol; 2018 Sep; 84(9):1883-1905. PubMed ID: 29873098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Views of pharmacist prescribers, doctors and patients on pharmacist prescribing implementation.
    Stewart DC; George J; Bond CM; Diack HL; McCaig DJ; Cunningham S
    Int J Pharm Pract; 2009 Apr; 17(2):89-94. PubMed ID: 20214256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacist independent prescribing in secondary care: opportunities and challenges.
    Bourne RS; Baqir W; Onatade R
    Int J Clin Pharm; 2016 Feb; 38(1):1-6. PubMed ID: 26613738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What patient assessment skills are required by pharmacists prescribing systemic anti-cancer therapy? A consensus study.
    Allison J; Fisher J; Souter C; Bennie M
    J Oncol Pharm Pract; 2019 Dec; 25(8):1933-1944. PubMed ID: 31042136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacist prescribing: a cross-sectional survey of the views of pharmacists in Nigeria.
    Auta A; Strickland-Hodge B; Maz J; David S
    Int J Pharm Pract; 2018 Apr; 26(2):111-119. PubMed ID: 28497878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Piloting the United Kingdom 'Prescribing Safety Assessment' with pharmacist prescribers in Scotland.
    Reid F; Power A; Stewart D; Watson A; Zlotos L; Campbell D; McIntosh T; Maxwell S
    Res Social Adm Pharm; 2018 Jan; 14(1):62-68. PubMed ID: 28089608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Practice makes perfect: A systematic review of the expertise development of pharmacist and nurse independent prescribers in the United Kingdom.
    Abuzour AS; Lewis PJ; Tully MP
    Res Social Adm Pharm; 2018 Jan; 14(1):6-17. PubMed ID: 28202233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of pharmacist prescribing on patient outcomes in the hospital setting: a systematic review.
    Poh EW; McArthur A; Stephenson M; Roughead EE
    JBI Database System Rev Implement Rep; 2018 Sep; 16(9):1823-1873. PubMed ID: 30204671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stakeholders' views of UK nurse and pharmacist supplementary prescribing.
    Cooper R; Anderson C; Avery T; Bissell P; Guillaume L; Hutchinson A; Lymn J; Murphy E; Ratcliffe J; Ward P
    J Health Serv Res Policy; 2008 Oct; 13(4):215-21. PubMed ID: 18806179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stakeholders' views on granting prescribing authority to pharmacists in Nigeria: a qualitative study.
    Auta A; Strickland-Hodge B; Maz J
    Int J Clin Pharm; 2016 Aug; 38(4):960-7. PubMed ID: 27194098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrating pharmacists into primary care teams: barriers and facilitators.
    Jorgenson D; Laubscher T; Lyons B; Palmer R
    Int J Pharm Pract; 2014 Aug; 22(4):292-9. PubMed ID: 24279947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Key stakeholders' views on the potential implementation of pharmacist prescribing: A qualitative investigation.
    Jebara T; Cunningham S; MacLure K; Pallivalapila A; Awaisu A; Al Hail M; Stewart D
    Res Social Adm Pharm; 2020 Mar; 16(3):405-414. PubMed ID: 31253499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacist prescribing in the UK - a literature review of current practice and research.
    Tonna AP; Stewart D; West B; McCaig D
    J Clin Pharm Ther; 2007 Dec; 32(6):545-56. PubMed ID: 18021331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 'It's showed me the skills that he has': pharmacists' and mentors' views on pharmacist supplementary prescribing.
    Lloyd F; Parsons C; Hughes CM
    Int J Pharm Pract; 2010 Feb; 18(1):29-36. PubMed ID: 20405593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advancing pharmacist prescribing privileges: Is it time?
    Majercak KR
    J Am Pharm Assoc (2003); 2019; 59(6):783-786. PubMed ID: 31521588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New Zealand pharmacists' views regarding the current prescribing courses: questionnaire survey.
    Ghabour M; Morris C; Wilby K; Smith A
    J Prim Health Care; 2023 Dec; 15(4):324-332. PubMed ID: 38112706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The development of a role description and competency map for pharmacists in an interprofessional care setting.
    Benson H; Lucas C; Benrimoj SI; Williams KA
    Int J Clin Pharm; 2019 Apr; 41(2):391-407. PubMed ID: 30879217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nurse and pharmacist supplementary prescribing in the UK--a thematic review of the literature.
    Cooper RJ; Anderson C; Avery T; Bissell P; Guillaume L; Hutchinson A; James V; Lymn J; McIntosh A; Murphy E; Ratcliffe J; Read S; Ward P
    Health Policy; 2008 Mar; 85(3):277-92. PubMed ID: 17900744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.